Symbiosis Pharmaceutical

Activities: Manufacturing

Symbiosis Pharmaceutical Services is a contract development and manufacturing organisation (CMO) specialising in the GMP manufacture and sterile fill/finish of vials for clinical trials and commercial supply. Regulatory compliance, technical capability and operational flexibility are at its core.

Visit website

Profile

Follow us on Twitter: @SymbiosisPharma

Manufacturing from a purpose-built FDA inspected and MHRA-licensed facility, the CMO can handle products that require aseptic liquid filling and lyophilisation for a range of complex biologics, viral vectors for use in gene therapies and small molecule drugs.

Offering fast access to manufacturing slots and accelerated release of drug product, Symbiosis is primed to meet demand for small-scale, fast-turnaround drug product sterile manufacturing.

 

 

Symbiosis Pharmaceutical

 

 

 

Trending Articles

  1. Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector...
  2. Dual-chamber packaging systems as a simplification factor in the supply chain Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making...
  3. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  4. BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical...
  5. Olon releases its annual ESG report The Italian Group, leading international API supplier, presents the 2023 sustainability report and confirms the sustainability journey toward energy transition, investments in...

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Manufacturing

Symbiosis enhances sterile injectable manufacturing capacity with novel UK site

The Sterling site will allow for the automated and sterile manufacture of injectable drug products, with a maximum batch size of 15,000 vials
Cell & Gene Therapy

Symbiosis Pharmaceutical Services shares the industry events it will attend in 2024

The aseptic manufacturing specialists will have an exhibiting presence at an additional 5 events globally this year
Regulatory

Symbiosis Pharmaceutical Services granted MHRA licence following a £1m investment

Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and advanced therapeutic medicinal products (ATMP) biopharmaceuticals following a £1m-plus investment
Manufacturing

Symbiosis expands capabilities with BSL-2 manufacturing upgrade

Contract manufacturing organisation Symbiosis Pharmaceutical Services has announced an expansion of its capabilities to handle novel and emerging treatments, such as viral based gene and oncolytic-therapies
Manufacturing

Symbiosis announces successful completion of UK Research and Innovation (UKRI) project

The project learnings will now accelerate the manufacturing supply chain for ATMPs within the UK.
Finance

Symbiosis announces £1 million investment in analytical testing capability

The new testing capability will include dedicated microbiology laboratories as well as temperature and humidity-controlled stability storage capabilities
Manufacturing

Symbiosis completes project to improve UK ATMPs manufacturing

ATMP therapy developers can reportedly save several weeks of precious drug development time
Subscribe now